KRASG12C IN-14

MedChem Express

KRASG12C IN-14

9

Research Use Only

C51H65F4N9O9S2

1088.24

KRASG12C IN-14 (compound 15) is an inhibitor targeting the KRAS G12C mutation. KRASG12C IN-14 inhibits CYPA-dependent KRAS-BRAF with an IC50 of 0.002 microM. KRASG12C IN-14 inhibits ERK phosphorylation in NCI-H358 cells with an IC50 of 0.002 microM[1].

O=C(OCC(C)(C)CC1=[C@@]([C@@]2=C([C@@H](OC)C)N=CC(N3CCOCC3)=C2)N(CC(F)(F)F)C4=C1C=C5C=C4)[C@H]6NN(C([C@@H](NC([C@H](C(C)C)N(C(N7CC(/C=C(S(C)(=O)=O)\F)C7)=O)C)=O)CC8=NC5=CS8)=O)CCC6

12352200